Journal article
Outcome measures in rheumatoid arthritis: The OMERACT process
P Brooks, M Boers, LS Simon, V Strand, P Tugwell
Expert Review of Clinical Immunology | Published : 2007
Abstract
The development of valid outcome measures is essential for appropriate management of any condition, but particularly chronic rheumatic diseases, such as rheumatoid arthritis. Over the last 15 years, Outcome Measures in Arthritis Clinical Trials has been dedicated to developing such measures in a variety of musculoskeletal conditions, including rheumatoid arthritis, osteoarthritis, osteoporosis, ankylosing spondylitis and gout. © 2007 Future Drugs Ltd.